SynthesisPloS one2022

Association of cognitive function with increased risk of cancer death and all-cause mortality: Longitudinal analysis, systematic review, and meta-analysis of prospective observational studies.

What the trial testedas reported · 2022

Range includes no effect

−21%−64% to +70%

Bigger than 5 in 10 for adverse events & safety

As reported

HR 0.79, 95% CI 0.36–1.70

the abstract, start to end

… had a lower chance of cancer death (HR 0.79, 95%CI 0.36-1.70, P for trend = …

← favours treatmentfavours comparator →

could be chance

Adverse events & safety

HR 0.790.36–1.70

StatinsAdverse events & safety

1 / 3

2022

2023

2024

2025

2026

this papercites it